Evidence map›Paper›PMID 33947079›Full record

ReviewMolecules (Basel, Switzerland)2021

AQP3 and AQP5-Potential Regulators of Redox Status in Breast Cancer.

Lidija Milković, Ana Čipak Gašparović

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2024
    Review
  5. Article
  6. Article
  7. AQP3-Dependent PI3K/Akt Modulation in Breast Cancer Cells.International journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Redox Active Molecules in Cancer Treatments.Molecules (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lidija MilkovićDivision of Molecular Medicine, Ruđer Bošković Institute, HR-10000 Zagreb, Croatia.ORCID 0000-0002-4484-039X
Ana Čipak GašparovićDivision of Molecular Medicine, Ruđer Bošković Institute, HR-10000 Zagreb, Croatia.ORCID 0000-0003-2000-8950
Ruđer Bošković Institute · HR

Funding

HrZZ IP-2020-02-3617
6 · The paper itself

Abstract

Breast cancer is still one of the leading causes of mortality in the female population. Despite the campaigns for early detection, the improvement in procedures and treatment, drastic improvement in survival rate is omitted. Discovery of aquaporins, at first described as cellular plumbing system, opened new insights in processes which contribute to cancer cell motility and proliferation. As we discover new pathways activated by aquaporins, the more we realize the complexity of biological processes and the necessity to fully understand the pathways affected by specific aquaporin in order to gain the desired outcome-remission of the disease. Among the 13 human aquaporins, AQP3 and AQP5 were shown to be significantly upregulated in breast cancer indicating their role in the development of this malignancy. Therefore, these two aquaporins will be discussed for their involvement in breast cancer development, regulation of oxidative stress and redox signalling pathways leading to possibly targeting them for new therapies.

Indexed as

Oxidation-ReductionAnimalsAntioxidantsAquaporin 3Aquaporin 5BiomarkersBreast NeoplasmsDisease SusceptibilityFemaleGene Expression Regulation, NeoplasticHumansMultigene FamilyOxidative StressAntioxidantsAQP3 protein, humanAQP5 protein, humanAquaporin 3Aquaporin 5BiomarkersAQP3AQP5oxidative stress

Identifiers

PMID33947079
PMCPMC8124745
OpenAlexW3159482010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.